Nipple Sparing Mastectomy - Cosmetic Outcomes

Sponsor
Wake Forest University Health Sciences (Other)
Overall Status
Completed
CT.gov ID
NCT01002014
Collaborator
(none)
75
1
1
115.9
0.6

Study Details

Study Description

Brief Summary

The purpose of this study is to observe the cosmetic outcomes, patient satisfaction, and complications after skin sparing mastectomy with preservation of the nipple areolar complex.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Nipple Sparing Mastectomy
N/A

Detailed Description

The outcomes will be observed in patients with both known cancer diagnosis and in those with indications for prophylactic mastectomy. The cosmetic appearance and complications will be followed through several post operative visits throughout the duration of the study. This study is conducted in conjunction with the plastic and reconstructive surgeons who will be performing the breast reconstruction procedures. Patient satisfaction will be measured via survey format. In addition, local recurrence rates will be compared to patients undergoing traditional mastectomy.

Study Design

Study Type:
Interventional
Actual Enrollment :
75 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Preservation of the Nipple Areolar Complex With Skin Sparing Mastectomy
Actual Study Start Date :
Jan 21, 2009
Actual Primary Completion Date :
Aug 24, 2016
Actual Study Completion Date :
Sep 20, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Nipple Sparing Mastectomy

Patients who undergo nipple sparing mastectomy with preservation of the nipple areolar complex.

Procedure: Nipple Sparing Mastectomy
Skin sparing mastectomy with preservation of the nipple areolar complex

Outcome Measures

Primary Outcome Measures

  1. Cosmetic Appearance [First Post Operative year]

  2. Patient Satisfaction [First Post Operative Year]

  3. Presence of tumor in nipple areolar complex frozen section [Duration of Study]

  4. Presence of tumor in nipple areolar complex permanent histology [Duration of study]

Secondary Outcome Measures

  1. Complications [First Post Operative year]

  2. Local Recurrence [One year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients requiring mastectomy for cancer and/or prophylaxis

  • Age greater than or equal to 18 at time of surgery

  • BMI less than or equal to 35

  • If mastectomy is indicated for removal of breast cancer, tumor is clinically T1 or T2

Exclusion Criteria:
  • Currently smoking

  • Prior radiation to the affected breast

  • Systemic lupus erythematosus

  • Central tumor location and/or tumor within 2 cm of NAC

  • Paget's disease of the nipple

  • Clinical evidence of tumor involvement in the nipple

  • Clinical evidence of axillary nodal tumor involvement

  • Lymphovascular invasion of the tumor on core biopsy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Levine Cancer Institute Charlotte North Carolina United States 28204

Sponsors and Collaborators

  • Wake Forest University Health Sciences

Investigators

  • Principal Investigator: Richard L White, MD, Carolinas Healthcare

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Wake Forest University Health Sciences
ClinicalTrials.gov Identifier:
NCT01002014
Other Study ID Numbers:
  • LCI NAC-SSM
First Posted:
Oct 27, 2009
Last Update Posted:
Apr 21, 2022
Last Verified:
Jan 1, 2019

Study Results

No Results Posted as of Apr 21, 2022